Theralase Technologies Inc.
TLTFF
$0.1378
-$0.0012-0.86%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -51.23% | 9.69% | 21.46% | -54.79% | -15.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -51.23% | 9.69% | 21.46% | -54.79% | -15.01% |
| Cost of Revenue | -35.43% | -0.85% | 3.19% | -35.08% | -0.83% |
| Gross Profit | -79.83% | 16.63% | 39.39% | -74.78% | -32.60% |
| SG&A Expenses | 1.09% | -0.52% | -0.41% | -16.86% | -2.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.36% | -4.84% | -1.80% | -11.72% | -10.40% |
| Operating Income | -9.75% | 10.13% | 8.21% | 3.61% | 9.74% |
| Income Before Tax | -9.11% | 9.95% | 9.22% | 3.66% | 9.81% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.11% | 9.95% | 9.22% | 3.66% | 9.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.11% | 9.95% | 9.22% | 3.66% | 9.81% |
| EBIT | -9.75% | 10.13% | 8.21% | 3.61% | 9.74% |
| EBITDA | -10.54% | 10.17% | 8.17% | 3.28% | 9.87% |
| EPS Basic | 0.00% | 18.75% | 17.14% | 10.00% | 14.58% |
| Normalized Basic EPS | 0.00% | 20.00% | 18.18% | 12.00% | 13.33% |
| EPS Diluted | 0.00% | 18.75% | 17.14% | 10.00% | 14.58% |
| Normalized Diluted EPS | 0.00% | 20.00% | 18.18% | 12.00% | 13.33% |
| Average Basic Shares Outstanding | 8.00% | 13.26% | 7.71% | 7.11% | 5.99% |
| Average Diluted Shares Outstanding | 8.00% | 13.26% | 7.71% | 7.11% | 5.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |